PGIM超短期债券主动型ETF PULS 深 沪
等待开盘 03-26 09:30:00 美东时间
49.65
0.000
0.00%
华盛通- 最 高49.66
- 今 开49.66
- 成交量 216.64万股
- 最 低 49.65
- 昨 收 49.65
- 总市值 142.30亿
- 52周最高 49.66
- 市盈率 静 --
- 换手率 0.76%
- 52周最低 47.1996
- 委 比 35.06%
- 总股本 2.87亿
- 历史最高 49.66
- 量 比 0.69
- 振 幅 0.02%
- 历史最低 36.3154
- 每 手 1
- 风险率 0.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Spire Global Demonstrates Single-Satellite Radio Frequency Geolocation Techniques On Orbit
On-orbit demonstration successfully identifies and geolocates S- and X-band radio frequency signal sourcesSpire Global, Inc. (NYSE:SPIR) ("Spire" or "the Company"), a global provider of space-based data, analytics and
03-24 18:48
BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data
BRIEF-Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data March 17 (Reuters) - Pulse Biosciences Inc PLSE.O : PULSE BIOSCIENCES ANNOUNCES STRATEGIC ALIGNMENT TO ACCELERATE CARDIAC CATHETER PROGRAM FOLLOWING EXCEPTI
03-17 19:53
Johnson & Johnson publishes 2025 annual report with USD 94.2 billion sales
Johnson & Johnson publishes 2025 annual report with USD 94.2 billion sales Johnson & Johnson published its 2025 annual report, outlining increased focus on six priority areas: Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision. The company reported 5% operational sales growth in
03-11 21:23
Pulsar Group Updates Register as Director Consolidates Shareholding
Access Intelligence ( ($GB:PULS) ) has provided an announcement. Pulsar Group p...
02-27 22:56
BRIEF-Pulse Biosciences To Offer Securities Worth $200 Million
BRIEF-Pulse Biosciences To Offer Securities Worth $200 Million Feb 19 (Reuters) - Pulse Biosciences Inc PLSE.O : PULSE BIOSCIENCES INC - TO OFFER SECURITIES WORTH $200 MILLION - SEC FILING Source text: [ID:n0001437749-26-004735] Further company coverage: PLSE.O (( Reuters.Briefs@thomsonreuters.com ;
02-20 06:02
BRIEF-Pulse Biosciences Says It Enters Equity Distribution Agreement With TD Securities
BRIEF-Pulse Biosciences Says It Enters Equity Distribution Agreement With TD Securities Feb 19 (Reuters) - Pulse Biosciences Inc PLSE.O : PULSE BIOSCIENCES INC - ENTERS EQUITY DISTRIBUTION AGREEMENT WITH TD SECURITIES - SEC FILING PULSE BIOSCIENCES INC - MAY SELL SHARES WORTH UP TO ABOUT $60 MILLION
02-20 05:44
BRIEF-PodcastOne Announces Signing Of Multi-Year Partnership With Gotavi
BRIEF-PodcastOne Announces Signing Of Multi-Year Partnership With Gotavi Feb 11 (Reuters) - Podcastone Inc PODC.O : PODCASTONE (NASDAQ: PODC), A SUBSIDIARY OF LIVEONE (NASDAQ: LVO) SIGNS MULTI-YEAR PARTNERSHIP WITH GOTAVI TO DEPLOY INTERACTOR AI AND PULSE, ACCELERATING AI-DRIVEN REVENUE GROWTH, MARG
02-11 23:33
BRIEF-Owlet Announces Strategic Dme Partnership With Promptcare To Expand Distribution Of Pediatric Pulse Oximeter, Babysat®
BRIEF-Owlet Announces Strategic Dme Partnership With Promptcare To Expand Distribution Of Pediatric Pulse Oximeter, Babysat® Feb 11 (Reuters) - Owlet Inc OWLT.N : OWLET ANNOUNCES STRATEGIC DME PARTNERSHIP WITH PROMPTCARE TO EXPAND DISTRIBUTION OF PEDIATRIC PULSE OXIMETER, BABYSAT® Source text: ID:nB
02-11 22:54
Johnson & Johnson Unveils NUVISION NAV Ultrasound Catheter at AF Symposium
Johnson & Johnson Unveils NUVISION NAV Ultrasound Catheter at AF Symposium Johnson & Johnson has announced the introduction of the VARIPULSE Plus Platform and the full commercial release of the NUVISION NAV Ultrasound Catheter at the 31st Annual AF Symposium. The company will present eleven accepted
02-03 21:02
Johnson & Johnson stellt neue klinische Daten und innovative Produkte zur Behandlung von Vorhofflimmern vor
Johnson & Johnson stellt neue klinische Daten und innovative Produkte zur Behandlung von Vorhofflimmern vor Johnson & Johnson hat auf dem 31. Annual AF Symposium in Boston neue wissenschaftliche Erkenntnisse und Portfolio-Innovationen im Bereich Vorhofflimmern (AFib) angekündigt. Im Rahmen der Veran
02-03 21:02
